The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children.
about
Tolerance and withdrawal from prolonged opioid use in critically ill children.Use of dexmedetomidine in the pediatric intensive care unit.Alpha2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients.Analysis of benzodiazepine withdrawal program managed by primary care nurses in Spain.Is it prime time for alpha2-adrenocepter agonists in the treatment of withdrawal syndromes?Dexmedetomidine for Sedation during Withdrawal of Support.Dexmedetomidine as an Adjuvant to Analgesic Strategy During Vaso-Occlusive Episodes in Adolescents with Sickle-Cell Disease.Characterization of spinal alpha-adrenergic modulation of nociceptive transmission and hyperalgesia throughout postnatal development in rats.Dexmedetomidine: an updated review.Dexmedetomidine: pediatric pharmacology, clinical uses and safety.Review article: dexmedetomidine: does it have potential in palliative medicine?Dexmedetomidine: applications for the pediatric patient with congenital heart disease.Dexmedetomidine: a review of applications for cardiac surgery during perioperative period.Dexmedetomidine Use in Critically Ill Children With Acute Respiratory Failure.Adjunctive dexmedetomidine therapy in the intensive care unit: a retrospective assessment of impact on sedative and analgesic requirements, levels of sedation and analgesia, and ventilatory and hemodynamic parameters.Neurologic withdrawal symptoms following abrupt discontinuation of a prolonged dexmedetomidine infusion in a child.Dexmedetomidine infusion for the management of opioid-induced hyperalgesia.Successful use of dexmedetomidine for sedation in a 24-week gestational age neonate.Use of dexmedetomidine to discontinue high-dose fentanyl.Dexmedetomidine for the treatment of postanesthesia shivering in children.
P2860
Q30428413-4493C194-5CED-42BF-9157-1A1D2A18F2DAQ30445277-AE2937E8-A73C-4001-82DC-292B59190E53Q33494795-C79C7B29-BE3E-41AC-8D7B-71B2C2A144F9Q34511412-02F03EDE-8494-43D8-9E94-A83775C14717Q34613312-BC8C0B2E-C0B1-41C3-873C-E4010DF2D649Q36000694-622CBA54-E23B-42A1-ADB1-DFC182794020Q36349495-23EAC947-61E3-40B4-8624-B4DDAAED3BDAQ36358102-C3AFB1DE-850C-4D11-8C99-EE10579B30F8Q36735205-CE39E684-B256-4311-B4C8-AA0134248C35Q37780765-C93B2028-FF33-429A-BA8A-B13F44A04E6DQ37816062-B6A48F23-E782-46A1-893B-1478C2F024F7Q37930472-150C6C07-4B47-45BF-BB65-E9DCD81AD274Q38218903-4DD91F17-A898-4F01-B818-54B7E500F4A5Q39365412-CF993618-8564-4375-BAC3-BB6C3BA702B7Q40240359-B8461ACA-9669-48FD-BBCD-C4E82E020F8BQ41680917-D77F2908-3658-4858-A206-8A0FC51E539EQ42840099-9C867FFF-397B-455A-A448-AFB4C4D9CB12Q43276347-37D8D31D-34A4-4032-B6B5-547B1E429303Q48215988-1739116F-1C25-497A-8A71-567CD034CF38Q48614654-050BDD95-D016-441A-99C5-4C60CFCB4F0E
P2860
The use of dexmedetomidine to facilitate acute discontinuation of opioids after cardiac transplantation in children.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
The use of dexmedetomidine to ...... c transplantation in children.
@ast
The use of dexmedetomidine to ...... c transplantation in children.
@en
type
label
The use of dexmedetomidine to ...... c transplantation in children.
@ast
The use of dexmedetomidine to ...... c transplantation in children.
@en
prefLabel
The use of dexmedetomidine to ...... c transplantation in children.
@ast
The use of dexmedetomidine to ...... c transplantation in children.
@en
P1476
The use of dexmedetomidine to ...... ac transplantation in children
@en
P2093
Julia C Finkel
Yewande J Johnson
P304
P356
10.1097/01.CCM.0000178183.21883.23
P407
P577
2005-09-01T00:00:00Z